Levi & Korsinsky announces it has commenced an investigation of Rockwell Medical, Inc. (“Rockwell” or “the Company”) (NASDAQGM: RMTI) concerning possible violations of federal securities laws. On May 22, 2018, Rockwell announced that its President and Chief Executive Officer, Robert Chioini, had been terminated. The following day, two Form 8-Ks were filed by the Company, the first of which denied the firing had occurred. The second 8-K stated that Chioini had been terminated, and that due to the filing of an unauthorized 8-K by Chioini and CFO Thomas Klema, the Board had voted to remove Klema from his roles at the Company. In a press release issued May 24, 2018, the Company stated that Chioini was terminated following “a thorough review of the business” and the determination that “Mr. Chioini lacked key attributes necessary to oversee the growth and long-term success of the Company…” To obtain additional information on the Rockwell class action investigation (RMTI class action investigation), go to: http://www.zlk.com/pslra-d/rockwell-medical-inc or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.